跳至主要内容
临床试验/NCT02350049
NCT02350049已完成不适用

Cementless Oxford Partial Knee Retrospective and Prospective Controlled Multi-center Observational Study

Zimmer Biomet0 个研究点目标入组 391 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Zimmer Biomet
入组人数
391
主要终点
Composite Endpoint- Safety & Efficacy (Radiographic Success, American Knee Society Score, Absence of Revision / Removal / Unanticipated Adverse Device Affects)

研究概览

简要总结

The purpose of this study is to evaluate the safety and effectiveness of the Cementless Oxford Partial Knee System.

详细描述

The study is designed to document and compare the clinical and radiographic results of the Cementless Oxford Partial Knee System (investigational device) to those of the cemented Oxford Partial Knee System (control device).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • have primary diagnosis of osteoarthritis or avascular necrosis limited to the medial compartment of the knee
  • signed informed consent for patients contributing to investigational or control if required
  • Male or female over the age of 21 years at the time of surgery
  • Undergone primary partial knee arthroplasty as unilateral arthroplasty or bilateral arthroplasty, simultaneously or otherwise
  • Patients that are current residents of the United Kingdom

排除标准

  • Evidence of infection, sepsis, and osteomyelitis at the time of surgery
  • Use in the lateral compartment of the knee
  • Rheumatoid arthritis or other forms of inflammatory joint disease
  • Revision of a failed prosthesis, failed upper tibial osteotomy or post-traumatic arthritis after tibial plateau fracture
  • Insufficiency of the collateral, anterior, or posterior cruciate ligaments which would preclude stability of the device
  • Partial or full thickness cartilage disease or damage to central part of the lateral femoral condyle
  • Osteoporosis or insufficient bone stock
  • Metabolic disorders which may impair bone formation
  • Osteomalacia
  • Distant foci of infection which may spread to the implant site
  • Rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram
  • Vascular insufficiency, muscular atrophy, neuromuscular disease
  • Incomplete or deficient soft tissue surrounding the knee
  • Charcot's disease
  • A fixed varus deformity (not passively correctable) of greater than 15 degrees
  • A flexion deformity greater than 15 degrees
  • Refuse to sign informed consent if it is required
  • Patients that are not current residents of the United Kingdom

结局指标

主要结局

Composite Endpoint- Safety & Efficacy (Radiographic Success, American Knee Society Score, Absence of Revision / Removal / Unanticipated Adverse Device Affects)

时间窗: 22+months

Radiographic Success, American Knee Society Score, Absence of Revision / Removal / Unanticipated Adverse Device Affects

次要结局

  • Survivorship (Cementless Only)(22+ Months)
  • Oxford Knee Score(0-16 Weeks, 6 Months, 12 Months, 22+ Months)
  • American Knee Society Score(0-16 Week, 6 Month, 12 Month)
  • Adverse Events(Through 22+ Months Postop)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

相似试验